ZubairAQureshiMD

PubMed

• 255 citations
  Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
  Zubair A. Qureshi, Lauren E. Hittle, Jessica A. O'Hara, Jesabel I. Rivera, Ryan K. Shields, Anthony W. Pasculle, Robert K. Ernst, Yohei Doi, Alveena Syed> ;Clinical Infectious Diseases. 2015 May 1
• 27 citations
  Epidemiology and Clinical Outcomes of Patients with Carbapenem-Resistant Klebsiella pneumoniae Bacteriuria
  Zubair A. Qureshi, Lloyd Clarke, Yohei Doi, Ryan K. Shields, Alveena Syed> ;Antimicrobial Agents and Chemotherapy. 2014 Jun 1
• 16 citations
  Escherichia coli sequence type 131: epidemiology and challenges in treatment
  Zubair A. Qureshi, Yohei Doi> ;Expert Review of Anti-Infective Therapy. 2014 Apr 10
• 15 citations
  Safety and Efficacy of Long-Term Outpatient Ertapenem Therapy
  Zubair A. Qureshi, Yohei Doi, Alveena Syed> ;Antimicrobial Agents and Chemotherapy. 2014 Jun 1
• 10 citations
  Role of ultraviolet (UV) disinfection in infection control and environmental cleaning.
  Zubair A. Qureshi, Mohamed Yassin> ;Infectious Disorders Drug Targets. 2013 May 31
• 45 citations
  Features of Infections Due to Klebsiella pneumoniae Carbapenemase–Producing Escherichia coli: Emergence of Sequence Type 131
  Young Ah Kim, Zubair A. Qureshi, Jennifer M. Adams-Haduch, Yoon Soo Park, Kathleen A. Shutt, Yohei Doi> ;Clinical Infectious Diseases. 2012 Jul 15
• Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.
  Qureshi, Z. A.,Paterson, D. L.,Peleg, A. Y.,Adams-Haduch, J. M.,Shutt, K. A.,Pakstis, D. L.,Sordillo, E.,Polsky, B.,Sandkovsky, G.,Bhussar, M. K.,Doi, Y.> ;Clin. Microbiol. Infect.. 2011 Sep 29
• 405 citations
  Treatment Outcome of Bacteremia due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
  Zubair A. Qureshi, David L. Paterson, Brian A. Potoski, Mary C. Kilayko, Gabriel Sandovsky, Emilia Mia Sordillo, Bruce Polsky, Jennifer M. Adams-Haduch, Yohei Doi> ;Antimicrobial Agents and Chemotherapy. 2012 Apr 1
• 28 citations
  Ochroconis gallopava: a dematiaceous mold causing infections in transplant recipients.
  Zubair A. Qureshi, Eun J. Kwak, M. Hong Nguyen, Fernanda P. Silveira> ;Clinical Transplantation. 2012 Jan 1
• Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role...
  Waltner-Toews, R.I., Paterson, D.L., Qureshi, Z.A., Sidjabat, H.E., Adams-Haduch, J.M., Shutt, K.A., Jones, M., Tian, G., Pasculle, A.W., Doi, Y.> ;Antimicrob Agents Chemother. 2011 Feb
• 53 citations
  Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
  Zubair A. Qureshi, David L. Paterson, Diana L. Pakstis, Jennifer M. Adams-Haduch, Gabriel Sandkovsky, Emilia Mia Sordillo, Bruce Polsky, Anton Y. Peleg, Manveen K. Bhu...> ;International Journal of Antimicrobial Agents. 2011 Jan 1
• 5 citations
  CTX-M-35 extended-spectrum β-lactamase conferring ceftazidime resistance in Citrobacter koseri
  Guo Bao Tian, Jennifer M. Adams-Haduch, Zubair A. Qureshi, Hong Ning Wang, Yohei Doi> ;International Journal of Antimicrobial Agents. 2010 Apr 1
• 108 citations
  Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain
  Yohei Doi, David L. Paterson, Pilar Egea, Álvaro Pascual, Lorena López-Cerero, María Dolores González-Ripoll Navarro, Jennifer M. Adams-Haduch, Zubair A. Qureshi, Hann...> ;Clinical Microbiology and Infection. 2010 Jan 1
• 48 citations
  Rebuilding the health care system in Afghanistan: an overview of primary care and emergency services
  John R. Acerra, Kara Iskyan, Zubair A. Qureshi, Rahul K. Sharma> ;International Journal of Emergency Medicine. 2009 Jun 5
• 43 citations
  Clinical Features and Molecular Epidemiology of CMY-Type β-Lactamase–Producing Escherichia coli
  Hanna E. Sidjabat, David L. Paterson, Zubair A. Qureshi, Jennifer M. Adams-Haduch, Alexandra O'Keefe, Álvaro Pascual, Jesús Rodríguez-Baño, Yohei Doi> ;Clinical Infectious Diseases. 2009 Mar 15
• 255 citations
  Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
  Anton Y. Peleg, Shahid Husain, Zubair A. Qureshi, Fernanda P. Silveira, Molade Sarumi, Kathleen A. Shutt, Eun J. Kwak, David L. Paterson> ;Clinical Infectious Diseases. 2007 May 15
• How to succeed in the MRCGP.
  Zubair Qureshi, Niroshan Siriwardena> ;The Practitioner. 2004 Oct 6
• Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
  Johnson, L. E., D'Agata, E. M., Paterson, D. L., Clarke, L., Qureshi, Z. A., Potoski, B. A., Peleg, A. Y.> ;Transpl Infect Dis. 2009 Jun
• Join now to see all